ArticleJMIR research protocols2022

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Michael Feher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.